Nicholas J. Silvestri, MD, recounts how the 2025 American Academy of Neurology meeting was an exciting and energizing event, particularly in the realm of myasthenia gravis (MG), where numerous new ...

Myasthenia gravis (MG) has been treatable for nearly 100 years. In 1934, the Scottish doctor Mary Broadfoot Walker, MD, discovered that the drug physostigmine improved muscle function in people with ...

It’s a lifelong autoimmune neuromuscular disease. It causes certain muscles to weaken easily after you use them. Muscle fatigue typically varies throughout the day (sometimes hour by hour) and gets ...

Ocular myasthenia gravis is an autoimmune condition affecting the muscles surrounding and involving the eyes. Symptoms can include double vision, droopy eyelids, and more. Ocular myasthenia gravis ...

Francisco J. Rivera Rosario is a science communications editor experienced in developing all types of science content including, scientific journal articles, infographics, medical educational videos, ...

Myasthenia gravis is an autoimmune disorder that disrupts communication between nerve cells and muscles. It can cause muscle weakness and other symptoms depending on the affected areas. Myasthenia ...

A new study looked at mortality trends in the U.S. among more than 37,000 individuals with MG over a 23-year period. Age-adjusted mortality rates in MG increased significantly over the study period, ...

Five therapies are currently approved by the FDA for treating the symptoms of myasthenia gravis, allowing partial to complete remission. Research suggests that five new therapies may become available ...

Although fatigue is a common medical complaint, fatigue related to myasthenia gravis has several key features: localized muscle weakness in a characteristic distribution,1 which is exacerbated by ...

Myasthenia gravis is a rare neuromuscular disease in which the voluntary muscles quickly become tired and weak as a result of dysfunction with nerve and muscle communication. Myasthenia gravis (MG) is ...

Myasthenia gravis is an autoimmune disease in which antibodies bind to acetylcholine receptors or to functionally related molecules in the postsynaptic membrane at the neuromuscular junction. The ...